» Articles » PMID: 37195006

Computed Tomography-based Radiomics Nomogram for the Pre-operative Prediction of BRAF Mutation and Clinical Outcomes in Patients with Colorectal Cancer: a Double-center Study

Overview
Journal Br J Radiol
Specialty Radiology
Date 2023 May 17
PMID 37195006
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To develop and validate a radiomics nomogram based on CT for the pre-operative prediction of BRAF mutation and clinical outcomes in patients with colorectal cancer (CRC).

Methods: A total of 451 CRC patients (training cohort = 190; internal validation cohort = 125; external validation cohort = 136) from 2 centers were retrospectively included. Least absolute shrinkage and selection operator regression was used to select radiomics features and the radiomics score (Radscore) was calculated. Nomogram was constructed by combining Radscore and significant clinical predictors. Receiver operating characteristic curve analysis, calibration curve and decision curve analysis were used to evaluate the predictive performance of the nomogram. Kaplan‒Meier survival curves based on the radiomics nomogram were used to assess overall survival (OS) of the entire cohort.

Results: The Radscore consisted of nine radiomics features which were the most relevant to BRAF mutation. The radiomics nomogram integrating Radscore and clinical independent predictors (age, tumor location and cN stage) showed good calibration and discrimination with AUCs of 0.86 (95% CI: 0.80-0.91), 0.82 (95% CI: 0.74-0.90) and 0.82 (95% CI: 0.75-0.90) in the training cohort, internal validation and external validation cohorts, respectively. Furthermore,the performance of nomogram was significantly better than that of the clinical model ( < 0.05). The radiomics nomogram-predicted BRAF mutation high-risk group had a worse OS than the low-risk group ( < 0.0001).

Conclusion: The radiomics nomogram showed good performance in predicting BRAF mutation and OS of CRC patients, which could provide valuable information for individualized treatment.

Advances In Knowledge: The radiomics nomogram could effectively predict BRAF mutation and OS in patients with CRC. High-risk BRAF mutation group identified by the radiomics nomogram was independently associated with poor OS.

Citing Articles

Radiomics in precision medicine for colorectal cancer: a bibliometric analysis (2013-2023).

Li H, Zhuang Y, Yuan W, Gu Y, Dai X, Li M Front Oncol. 2024; 14:1464104.

PMID: 39558950 PMC: 11571149. DOI: 10.3389/fonc.2024.1464104.


Machine Learning and Radiomics Analysis for Tumor Budding Prediction in Colorectal Liver Metastases Magnetic Resonance Imaging Assessment.

Granata V, Fusco R, Brunese M, Ferrara G, Tatangelo F, Ottaiano A Diagnostics (Basel). 2024; 14(2).

PMID: 38248029 PMC: 10814152. DOI: 10.3390/diagnostics14020152.

References
1.
Xue T, Peng H, Chen Q, Li M, Duan S, Feng F . A CT-Based Radiomics Nomogram in Predicting the Postoperative Prognosis of Colorectal Cancer: A Two-center Study. Acad Radiol. 2022; 29(11):1647-1660. DOI: 10.1016/j.acra.2022.02.006. View

2.
De Jay N, Papillon-Cavanagh S, Olsen C, El-Hachem N, Bontempi G, Haibe-Kains B . mRMRe: an R package for parallelized mRMR ensemble feature selection. Bioinformatics. 2013; 29(18):2365-8. DOI: 10.1093/bioinformatics/btt383. View

3.
Atreya C, Greene C, McWhirter R, Ikram N, Allen I, Van Loon K . Differential Radiographic Appearance of BRAF V600E-Mutant Metastatic Colorectal Cancer in Patients Matched by Primary Tumor Location. J Natl Compr Canc Netw. 2016; 14(12):1536-1543. PMC: 5551390. DOI: 10.6004/jnccn.2016.0165. View

4.
Sepulveda A, Hamilton S, Allegra C, Grody W, Cushman-Vokoun A, Funkhouser W . Molecular Biomarkers for the Evaluation of Colorectal Cancer: Guideline From the American Society for Clinical Pathology, College of American Pathologists, Association for Molecular Pathology, and American Society of Clinical Oncology. J Mol Diagn. 2017; 19(2):187-225. PMC: 5971222. DOI: 10.1016/j.jmoldx.2016.11.001. View

5.
Dekker E, Tanis P, Vleugels J, Kasi P, Wallace M . Colorectal cancer. Lancet. 2019; 394(10207):1467-1480. DOI: 10.1016/S0140-6736(19)32319-0. View